Spotlight: Health Equity
Welcome to The Evidence Base Spotlight on the ‘Health Equity’.
Read selected coverage from The Evidence Base covering topics on health equity, including diversity and inclusion in clinical trials, HTA and the use of RWE.
For more content on Health Equity, click here.
Video, Insights & Feature content
Prescribing health: the vital role of the pharmaceutical sector in improving health equity
The life sciences sector has a unique opportunity to drive tractable action to reduce health inequalities. In this Guest Column, Dr Jonathan Pearson-Stuttard (LCP Health Analytics), Dr Chris Lübker (Novo Nordisk) and Thomas Holbaek (Novo Nordisk) highlight the increasing relevance of health equity to payers and health technology assessment (HTA) bodies, underscoring their critical role in shaping access to healthcare innovations.
Equity in evidence: how the pharmaceutical industry can advance health equity to drive better outcomes and value in health care
In this Deep Dive, we summarize some the key points discussed by Dr Jonathan Pearson-Stuttard (Head, LCP Health Analytics & Chair, Royal Society for Public Health), such as the growing importance of health equity for stakeholders including governments, payers, HTA bodies and the pharmaceutical industry.
Nancy A. Dreyer: There is a lot of discussion around diversity and inclusion in clinical trials, secondary data sources, etc. How much of a concern is this, from a drug approval and post-approval RWE standpoint?
From our Patti’s People series, in this question, Nancy A. Dreyer discusses diversity and inclusion in clinical trials.
Creating equity in healthcare decision making through real-world evidence: an interview with Grammati Sarri, Cytel
Following the ISPOR 2023 Issue Panel on ‘RWE and Health Disparities in HTAs: Is Transferability the Main Barrier for Equity Data Sharing Across Borders?’, we speak with Grammati Sarri (Cytel, UK) to understand more about this topic and learn how RWE is being leveraged to ensure wider representativeness across diverse patient groups in health technology development and assessment.
Achieving patient-centered, equity-focused health technology assessment with the Innovation and Value Initiative: an interview with Jennifer Bright
We speak with Jennifer Bright, Chief Engagement and Strategy Officer at IVI about the institute and the work they are doing to achieve patient-centered, equity-focused HTA.
Health equity in health technology assessment: an interview with Melanie Whittington
Following a workshop at the recent ISPOR 2023 conference, we spoke with Melanie Whittington of ICER to learn more about alternative methods that can be employed to assess the impact of a healthcare treatment on equity.
ICER white paper recommends health technology assessment strategies to improve health equity
ICER publishes their white paper proposing a series of recommendations and guidelines for health technology assessment to advance society’s ethical goal of improving health inequity related to racial, ethnic, and socioeconomic status.
Look behind the lecture: who and what are we missing in real-world data?
Michelle Tarver of the FDA explores how much progress has been made in including social determinants of health in real-world data.
Get in touch to discuss the opportunities available to share your expertise, contribute to this theme or to become a theme sponsor.
